semaglutide for type 1 and tirzepatide treatment leads to weight loss in diabetes GLP-1 Weight Loss Medication -

The 2% extra lean-mass loss at 12 months sounds small until you scale it: on a 100 kg starting weight with 25% body fat (25 kg fat, 75 kg lean), an extra 2% lean mass equals 1.5 kg of additional muscle attrition over a year roughly one full year of natural aging muscle loss, on top of whatever the drug class is already costing you

Different Uses for Wegovy and Ozempic Ozempic is FDA-approved to treat adults with Type 2 diabetes and to reduce cardiovascular disease risk in adults with Type 2 diabetes

Hepatic portal vein denervation impairs oral glucose tolerance but not exenatides effect on glycemia

Its best, when you can, not to mask your symptoms too much, so you know how serious your condition is, she says

Again, these aren't approved in New Zealand - and aren't as effective, Dr Wilde said